SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950123-11-031280
Filing Date
2011-03-31
Accepted
2011-03-31 12:56:18
Documents
2
Effectiveness Date
2011-03-31

Document Format Files

Seq Description Document Type Size
1 DEFA14A f58788defa14a.htm DEFA14A 16342
2 GRAPHIC f58788f5878801.gif GRAPHIC 3063
  Complete submission text file 0000950123-11-031280.txt   21720
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34637 | Film No.: 11724898
SIC: 2834 Pharmaceutical Preparations